Země: Velká Británie
Jazyk: angličtina
Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aciclovir
Waymade Healthcare Plc
J05AB01
Aciclovir
400mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05030201
Přečtěte si celý dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Aciclovir 400 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 400 mg tablet contains 400 mg aciclovir. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet White to off-white, round (diameter: 11.8 mm), biconvex, uncoated tablets debossed with ‘AR and 400’ separated with breakline on one side and plain on the other side. The tablet can be divided into equal doses 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Aciclovir Tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes (excluding neonatal HSV and severe HSV infections in immunocompromised children). Aciclovir Tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immunocompetent patients. Aciclovir Tablets are indicated for the prophylaxis of herpes simplex infections in immunocompromised patients. Aciclovir Tablets are indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Dosage in adults _ _ _ Treatment of herpes simplex infections: 200 mg Aciclovir should be taken five times daily at approximately four hourly intervals omitting the night time dose. Treatment should continue for 5 days, but in severe initial infections this may have to be extended. In severely immunocompromised patients (e.g. after marrow transplant) or in patients with impaired absorption from the gut the dose can be doubled to 400 mg Aciclovir, or alternatively, intravenous dosing could be considered. Dosing should begin as early as possible after the start of an infection; for recurrent episodes this should preferably be during the prodromal period or when lesions first appear. Suppression of herpes simplex infections in immunocompetent patients: 200 mg Aciclovir should be taken four times daily at approximately six-hourly intervals. Přečtěte si celý dokument